Searching for better biomarkers of heart risk and disease Bruce McManus Invited Commentary 29 March 2008 Pages: 79 - 81
Rosiglitazone evaluated for cardiovascular outcomes: An interim analysis of the RECORD trial L. Romayne KurukulasuriyaSamy I. McFarlane Clinical Trials Report 29 March 2008 Pages: 85 - 87
Carbohydrate restriction and cardiovascular risk Jocelyne G. KaramFiby NessimRichard D. Feinman OriginalPaper 29 March 2008 Pages: 88 - 94
The cardiometabolic syndrome and chronic kidney disease Preethi YerramPoorna R. KaruparthiAdam Whaley-Connell OriginalPaper 29 March 2008 Pages: 95 - 100
Obesity, obstructive sleep apnea, and cardiovascular risk Muhammad IqbalSyed ShahSamy I. McFarlane OriginalPaper 29 March 2008 Pages: 101 - 106
Cardiovascular imaging for the assessment of atherosclerotic disease: Implications for cardiac risk stratification Amgad N. Makaryus OriginalPaper 29 March 2008 Pages: 107 - 112
Obesity and cardiovascular risk Poorna R. KaruparthiPreethi YerramMelvin R. Hayden OriginalPaper 29 March 2008 Pages: 113 - 119
Obesity and vascular compliance Sudha GanneNathaniel Winer OriginalPaper 29 March 2008 Pages: 120 - 125
Is arterial stiffness better than blood pressure in predicting cardiovascular risk? Junichiro HashimotoMichael F. O’Rourke OriginalPaper 29 March 2008 Pages: 133 - 140
Is homocysteine a relevant cardiovascular risk factor? Jayanta DasSanjay Kaul OriginalPaper 29 March 2008 Pages: 141 - 149
Asymmetric dimethylarginine as a marker of metabolic dysfunction and cardiovascular disease Jennifer K. Pai OriginalPaper 29 March 2008 Pages: 156 - 160
Omega-3 fatty acids, acute coronary syndrome, and sudden death William S. HarrisClemens von Schacky OriginalPaper 29 March 2008 Pages: 161 - 166